Suppr超能文献

骨肉瘤细胞中HOTAIR与DNA甲基化之间的新型相互作用表明了一种新的治疗策略。

A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.

作者信息

Li Xingang, Lu Hongming, Fan Guilian, He Miao, Sun Yu, Xu Kai, Shi Fengjun

机构信息

Department of Orthopaedics, Heilongjiang General Hospital of Daqing Oil Field, Daqing, 163000, China.

Department of Pathology, Heilongjiang General Hospital of Daqing Oil Field, Daqing, 163000, China.

出版信息

J Cancer Res Clin Oncol. 2017 Nov;143(11):2189-2200. doi: 10.1007/s00432-017-2478-3. Epub 2017 Jul 20.

Abstract

PURPOSE

Osteosarcoma (OS) is one of the most prevalent primary malignant bone tumors in adolescent. HOTAIR is highly expressed and associated with the epigenetic modifications, especially DNA methylation, in cancer. However, the regulation mechanism between HOTAIR and DNA methylation and the biological effects of them in the pathogenesis of osteosarcoma remains elusive.

METHOD

Through RNA-sequencing and computational analysis, followed by a variety of experimental validations, we report a novel interplay between HOTAIR, miR-126, and DNA methylation in OS.

RESULTS

We found that HOTAIR is highly expressed in OS cells and the knockdown of HOTAIR leads to the down-regulation of DNMT1, as well as the decrease of global DNA methylation level. RNA-sequencing analysis of HOTAIR-regulated gene shows that CDKN2A is significantly repressed by HOTAIR. A series of experiments show that HOTAIR represses the expression of CDKN2A through inhibiting the promoter activity of CDKN2A by DNA hypermethylation. Further evidence shows that HOTAIR activates the expression of DNMT1 through repressing miR-126, which is the negative regulator of DNMT1. Functionally, HOTAIR depletion increases the sensibility of OS cells to DNMT1 inhibitor through regulating the viability and apoptosis of OS cells via HOTAIR-miR126-DNMT1-CDKN2A axis.

CONCLUSION

These results not only enrich our understanding of the regulation relationship between non-coding RNA, DNA methylation, and gene expression, however, also provide a novel direction in developing more sophisticated therapeutic strategies for OS patients.

摘要

目的

骨肉瘤(OS)是青少年中最常见的原发性恶性骨肿瘤之一。HOTAIR在癌症中高表达且与表观遗传修饰相关,尤其是DNA甲基化。然而,HOTAIR与DNA甲基化之间的调控机制及其在骨肉瘤发病机制中的生物学效应仍不清楚。

方法

通过RNA测序和计算分析,随后进行各种实验验证,我们报道了骨肉瘤中HOTAIR、miR-126和DNA甲基化之间的一种新型相互作用。

结果

我们发现HOTAIR在骨肉瘤细胞中高表达,敲低HOTAIR会导致DNMT1下调,以及整体DNA甲基化水平降低。对HOTAIR调控基因的RNA测序分析表明,CDKN2A受到HOTAIR的显著抑制。一系列实验表明,HOTAIR通过DNA高甲基化抑制CDKN2A的启动子活性来抑制CDKN2A的表达。进一步的证据表明,HOTAIR通过抑制DNMT1的负调节因子miR-126来激活DNMT1的表达。在功能上,HOTAIR的缺失通过HOTAIR-miR126-DNMT1-CDKN2A轴调节骨肉瘤细胞的活力和凋亡,从而增加骨肉瘤细胞对DNMT1抑制剂的敏感性。

结论

这些结果不仅丰富了我们对非编码RNA、DNA甲基化和基因表达之间调控关系的理解,而且还为开发更复杂的骨肉瘤患者治疗策略提供了新的方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验